How Efficacious Must a COVID-19 Coronavirus Vaccine be to Prevent or Stop an Epidemic by Itself - PubMed

How Efficacious Must a COVID-19 Coronavirus Vaccine be to Prevent or Stop an Epidemic by Itself - PubMed

Study Estimates How Many Americans Must Be Protected by a Vaccine in Order To Extinguish the COVID-19 Pandemic

A COVID-19 coronavirus vaccine given to 75 percent of the U.S. population must prevent at least 80 percent of infection cases in order to end the COVID-19 pandemic without social distancing measures, according to an AHRQ-funded modeling study published in the American Journal of Preventive Medicine. Researchers created a model that simulated the spread of the COVID-19 virus through the U.S. population. They then simulated administration of vaccinations to different proportions of the population to see what percentage of infection cases would need to be prevented in order to end the epidemic. In an additional scenario, researchers estimated that, if 100 percent of the population receives the vaccine, it will need to prevent at least 60 percent of cases in order to end the pandemic without social distancing measures. Access the abstract.

How Efficacious Must a COVID-19 Coronavirus Vaccine be to Prevent or Stop an Epidemic by Itself

Sarah M Bartsch, Kelly J O'Shea, Marie C Ferguson, Maria-Elena Bottazzi, Sarah N Cox, Ulrich Strych, James A McKinnell, Patrick T Wedlock, Sheryl S Siegmund, Peter J Hotez, Bruce Y Lee

• PMID: 32511569
 
• PMCID: PMC7274250
 
• DOI: 10.1101/2020.05.29.20117184

Free PMC article

Abstract

Background: Given the continuing coronavirus disease 2019 (COVID-19) pandemic and much of the U.S. implementing social distancing due to the lack of alternatives, there has been a push to develop a vaccine to eliminate the need for social distancing.

Methods: In 2020, we developed a computational model of the U.S. simulating the spread of COVID-19 coronavirus and vaccination.

Results: Simulation experiments revealed that when vaccine efficacy exceeded 70%, coverage exceeded 60%, and vaccination occurred on day 1, the attack rate dropped to 22% with daily cases not exceeding 3.2 million (reproductive rate, R0, 2.5). When R0 was 3.5, the attack rate dropped to 41% with daily cases not exceeding 14.4 million. Increasing coverage to 75% when vaccination occurred by day 90 resulted in 5% attack rate and daily cases not exceeding 258,029when R0 was 2.5 and a 26% attack rate and maximum daily cases of 22.6 million when R0 was 3.5. When vaccination did not occur until day 180, coverage (i.e., those vaccinated plus those otherwise immune) had to reach 100%. A vaccine with an efficacy between 40% and 70% could still obviate the need for other measures under certain circumstances such as much higher, and in some cases, potentially unachievable, vaccination coverages.

Conclusion: Our study found that to either prevent or largely extinguish an epidemic without any other measures (e.g., social distancing), the vaccine has to have an efficacy of at least 70%.

Similar articles

• Effect of the social distancing measures on the spread of COVID-19 in 10 highly infected countries.

  Thu TPB, Ngoc PNH, Hai NM, Tuan LA.Sci Total Environ. 2020 Jun 22;742:140430. doi: 10.1016/j.scitotenv.2020.140430. Online ahead of print.PMID: 32623158 Free PMC article.
• Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios.

  Mukandavire Z, Nyabadza F, Malunguza NJ, Cuadros DF, Shiri T, Musuka G.PLoS One. 2020 Jul 24;15(7):e0236003. doi: 10.1371/journal.pone.0236003. eCollection 2020.PMID: 32706790 Free PMC article.
• Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis.

  Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D.Int J Infect Dis. 2020 Apr;93:201-204. doi: 10.1016/j.ijid.2020.02.033. Epub 2020 Feb 22.PMID: 32097725 Free PMC article.
• BCG vaccination in India and tuberculosis in children: newer facets.

  Udani PM.Indian J Pediatr. 1994 Sep-Oct;61(5):451-62. doi: 10.1007/BF02751703.PMID: 7744445 Review.
• COVID-19, SARS and MERS: are they closely related?

  Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E.Clin Microbiol Infect. 2020 Jun;26(6):729-734. doi: 10.1016/j.cmi.2020.03.026. Epub 2020 Mar 28.PMID: 32234451 Free PMC article. Review.